Thomas W. Loewald's most recent trade in Harvard Bioscience Inc. was a trade of 45,872 Common Stock done . Disclosure was reported to the exchange on May 21, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harvard Bioscience Inc. | Thomas W. Loewald | Director | 21 May 2024 | 45,872 | 295,311 (0%) | 0% | 0 | Common Stock | ||
| Harvard Bioscience Inc. | Thomas W. Loewald | Director | 22 May 2023 | 25,554 | 249,439 (0%) | 0% | 0 | Common Stock | ||
| Harvard Bioscience Inc. | Thomas W. Loewald | Director | 24 May 2022 | 38,259 | 223,885 (0%) | 0% | 0 | Common Stock | ||
| Harvard Bioscience Inc. | Thomas W. Loewald | Director | 01 Jan 2022 | 2,525 | 185,626 (0%) | 0% | 0 | Common Stock | ||
| Harvard Bioscience Inc. | Thomas W. Loewald | Director | 28 Dec 2021 | 1,401 | 183,101 (0%) | 0% | 0 | Common Stock | ||
| Harvard Bioscience Inc. | Thomas W. Loewald | Director | 25 May 2021 | 14,400 | 181,700 (0%) | 0% | 0 | Common Stock | ||
| Harvard Bioscience Inc. | Thomas W. Loewald | Director | 04 Jan 2021 | 15,300 | 167,300 (0%) | 0% | 0 | Common Stock |